ABBOTT PARK, Illinois, Oct. 1, 2018 /PRNewswire/ -- People living with diabetes in Europe will now have the choice to be alerted in real-time of hypoglycemia (low glucose levels 1) or hyperglycemia ...

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes. The Food and Drug Administration (FDA) has ...

Wiesbaden. Das System „FreeStyle Libre 3“ zum kontinuierlichen Glukosemonitoring hat die CE-Kennzeichnung erhalten. Es darf damit in Europa für die Verwendung bei Diabetes in Verkehr gebracht werden, ...

- The FreeStyle Libre 3 system automatically delivers real-time, up-to-the-minute glucose readings, unsurpassed 14-day accuracy[1] and optional glucose alarms directly to smartphones[2] for people ...

ABBOTT PARK, Ill. & SAN DIEGO--(BUSINESS WIRE)--Abbott (NYSE: ABT), the global health care company, and Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology ...

Ambrosia Systems, a fast growing medical technology company, announced the launch of the next version of NightRider BluCon to work with FreeStyle Libre 2 sensor. The new NightRider BluCon also works ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced it has received CE mark approval ...

Mithilfe des Freestyle Libre erhalten Sie einen genauen Überblick über Ihren Blutzuckerspiegel. Die Daten werden dabei von einem am Körper angebrachten Sensor gesammelt. Tauschen Sie den Sensor in ...